In this review
Review the current service under its new name
OnlineSemaglutide.org now redirects to Raeliva, whose rebrand page identifies the same operating company and continuing CareValidate arrangements. The current weight-care catalogue lists compounded semaglutide and tirzepatide as injections and tablets that dissolve under the tongue. [1] [6]
I would identify the exact proposed preparation before comparing a plan. The product, route, actual pharmacy and usable supply matter more than choosing a familiar ingredient name from a menu. Prescribing remains a clinical decision. [2]
Compare the care arrangement in our provider comparisons.
The low headline is a prepaid equivalent
Semaglutide injection is listed at $219 month to month, $500 for three months or $900 for six. Tirzepatide injection lists $299, $800 and $1,450 for the same terms. The lower monthly equivalents are tied to upfront payments. [7] [8]
The sublingual semaglutide options are $260 monthly, $550 for three months and $1,000 for six; tirzepatide tablets list $359, $850 and $1,600. These are different preparations and commitments, not one universal drug price. Obtain the final selected charge and supply before ranking services. [9] [10]
Record the actual upfront commitment in the full treatment-cost planner.
A convenient route needs evidence for that product
Raeliva explicitly says its compounded medications are not FDA-approved and were not the products studied in the branded trials it cites. Its catalogue also states that oral dissolving tablets were not studied in those trials. That is a useful distinction to preserve when considering a needle-free format. [6]
FDA recommends compounded GLP-1 medicines only when a patient’s medical need cannot be met by an approved drug. A lower price or preferred route does not settle that need, nor demonstrate equal absorption, benefit or safety. The clinician must explain the proposed preparation rather than borrow the brand’s evidence. [11]
Keep the finished preparation specific with oral versus injectable treatment evidence.
Keep appetite promises in context with what food-noise studies measure.
Identify who provides the continuing care
The care-roles page separates Pacific Shores’ marketing site, CareValidate’s clinical and billing platform, an independent medical practice and a network of pharmacies. The actual responsible practice is confirmed during the care process; a network list does not establish your dispenser. [2]
Product panels describe prescription review, medication, shipping and clinical access as inclusions. Clarify laboratory requirements, monitoring and the route for clinical questions. A site accepting messages at any hour is not a promise of an immediate or emergency clinician response. [2] [7]
For a branded-pharmacy and separate-care-fee model, read our Nurx review.
Stopping renewal does not reverse a processed order
The site describes email or care-team cancellation with written confirmation. Its refund policy excludes processed prescriptions, dispensed or shipped medicine and completed consultations, while allowing specific pre-processing or verified-error exceptions. Those limits are more useful than the broad “cancel anytime” headline. [4]
CareValidate’s separate patient terms govern clinical billing and refunds. Review the selected agreement before payment, especially any prepaid balance and renewal timing. The general marketing terms also allow the final charge to vary with prescription and pharmacy, so get the actual confirmation rather than assume every price statement controls every order. [2] [3]
Discuss continuity alongside the evidence after GLP-1 treatment stops.
My comparison starts after the preparation is clear
Raeliva advertises a price that stays the same as dose changes and ongoing check-ins. That can simplify a budget comparison once the selected term, preparation and governing agreement are known. It does not establish clinical equivalence or a permanent right to a particular prescription. [6] [7] [8] [9] [10]
I would compare the useful follow-up and complete paid commitment with another service on the same assumptions. A claimed transfer at an established dose remains subject to clinical review, and individual testimonials should not set a personal weight-loss target. [1] [6]
For behavioral support bundled with clinical access, compare our Noom Med review.
For separate starter, transfer and regular refill terms, read our OrderlyMeds review.
Understanding the cost
Injection plans: semaglutide $219 monthly/$500 three months/$900 six months; tirzepatide $299/$800/$1,450. Sublingual tablets: semaglutide $260/$550/$1,000; tirzepatide $359/$850/$1,600. Multi-month terms are prepaid, not installments. Selected supply, additional testing, final charge and governing clinical terms need confirmation. [2] [7] [8] [9] [10]
Build your cost estimateSources
- Raeliva: rebrand from OnlineSemaglutide.org and account continuity
- Raeliva: independent care, CareValidate billing and pharmacy responsibilities
- Raeliva: July 27, 2026 terms and payment conditions
- Raeliva: processing, prescription and shipment refund limits
- FDA: compounded medicines and premarket review
- Raeliva: weight-care catalogue and branded-trial qualifications
- Raeliva: compounded semaglutide injection and paid terms
- Raeliva: compounded tirzepatide injection and paid terms
- Raeliva: compounded semaglutide dissolving tablets
- Raeliva: compounded tirzepatide dissolving tablets
- FDA: concerns with unapproved GLP-1 medicines
This review evaluates public service information. It does not claim patient enrollment, product testing or measurement of clinical outcomes.